|
UBE2CBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.091790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.017800E-01 |
| Normal-vs-Stage2 |
8.357600E-01 |
| Normal-vs-Stage3 |
1.316890E-03 |
| Normal-vs-Stage4 |
6.45470000000259E-05 |
| Stage1-vs-Stage2 |
9.699800E-01 |
| Stage1-vs-Stage3 |
1.014600E-04 |
| Stage1-vs-Stage4 |
2.94899999997433E-06 |
| Stage2-vs-Stage3 |
1.618650E-01 |
| Stage2-vs-Stage4 |
6.814100E-02 |
| Stage3-vs-Stage4 |
3.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.061620E-01 |
| Normal-vs-AfricanAmerican |
8.359200E-01 |
| Normal-vs-Asian |
3.320200E-01 |
| Caucasian-vs-AfricanAmerican |
5.607400E-01 |
| Caucasian-vs-Asian |
5.197400E-01 |
| AfricanAmerican-vs-Asian |
3.646400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.727820E-01 |
| Normal-vs-Female |
1.724570E-01 |
| Male-vs-Female |
9.585400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.053410E-01 |
| Normal-vs-Age(41-60Yrs) |
2.675600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.224200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.023400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.615400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.222400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.102200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.292200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.997800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.651200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.65219999999078E-05 |
| Normal-vs-Grade 2 |
1.728960E-01 |
| Normal-vs-Grade 3 |
2.725900E-02 |
| Normal-vs-Grade 4 |
5.23669996255194E-11 |
| Grade 1-vs-Grade 2 |
7.163300E-03 |
| Grade 1-vs-Grade 3 |
8.760600E-04 |
| Grade 1-vs-Grade 4 |
1.03389999894787E-08 |
| Grade 2-vs-Grade 3 |
2.316000E-03 |
| Grade 2-vs-Grade 4 |
5.90705262482061E-12 |
| Grade 3-vs-Grade 4 |
6.40899999959643E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.4192000000054E-05 |
| Normal-vs-ccB subtype |
3.46545014906496E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.321600E-01 |
| Normal-vs-N1 |
9.5152999999959E-05 |
| N0-vs-N1 |
9.791800E-04 |
|
|
